Guardian Pharmacy Services, Inc. GRDN
40.87 USD +0.87 (+2.17%)
At closeNov 4, 2026, 4:38 AM EST
41.51 +0.64 +1.57%
Pre-market · Nov 4, 4:38 AM ET
39.79 Day range 40.96
26.34 52-week range 48.33
- YTD
- +35.83%
- 1 year
- +43.45%
Financial health
Altman Z-Score
12.96 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 3
- P/E 1
- P/B 1
Valuation
P/E 38.1×
FY 2018 5y median 38.1× FY 2025
P/S 1.3×
FY 2018 5y median 1.1× FY 2025
P/B 9.1×
FY 2018 5y median 22.8× FY 2025
P/FCF 23.3×
FY 2018 5y median 23.3× FY 2025
EV/EBITDA 19.2×
FY 2018 5y median 17.7× FY 2025
EV/Sales 1.3×
FY 2018 5y median 1.1× FY 2025
FCF Yield 4.3%
FY 2018 5y median 4.3% FY 2025
Profitability
Gross Margin 19.5%
FY 2018 5y median 19.9% FY 2025
Operating Margin 6.1%
FY 2018 5y median 3.9% FY 2025
Net Margin 3.4%
FY 2018 5y median 2.3% FY 2025
ROE 23.9%
FY 2018 5y median 68.2% FY 2025
ROIC 22.9%
FY 2018 5y median 22.9% FY 2025
ROA 11.9%
FY 2018 5y median 8.8% FY 2025
Growth (YoY)
Revenue 17.9%
FY 2018 FY 2025
Operating Income 241.3%
FY 2018 FY 2025
EPS (diluted) 144.1%
FY 2018 FY 2025
Free Cash Flow 94.1%
FY 2018 FY 2025
Financial Health
Current Ratio 1.4×
FY 2018 5y median 1.1× FY 2025
Quick Ratio 1.1×
FY 2018 5y median 0.7× FY 2025
Debt / Equity 0.2×
FY 2018 5y median 1.5× FY 2025
Net Debt / EBITDA -0.3×
FY 2018 5y median 0.9× FY 2025
Interest Coverage 134×
FY 2018 5y median 18.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 2.8% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 87.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
